Burns Clinical Trial
Fluid resuscitation in burn patients is associated with major macrocirculatory and
microcirculatory disturbances that have been poorly described. When done according to expert
opinions, it is now rare to encounter the death of a patient due to an inadequate fluid
resuscitation. Fluid resuscitation in burn patients is more opinion-based than
evidence-based. Although burn admission to an intensive care facility is relatively rare,
the burn patient is well suited to answer questions in the fluid resuscitation field
because, as opposed to other critically ill patients:
1. investigators do have a time ‘zero’ for burn patients; they know exactly when the
insult occurred;
2. apart from fluid resuscitation, the management of burn patients is uniform in the
investigators' unit and is done according to various protocols;
3. the burn population is more uniform than the septic population making confounders and
background noises less likely; and
4. as basic as it might sound, studying fluid resuscitation implies accomplishing a
significant one; burn patients are the category of critically ill patients receiving
the most important fluid resuscitation.
Studies that have addressed the question of fluid resuscitation in burn patients are quite
numerous. However, they are either under-powered, dealing with various interventions or
outcomes and sometimes of poor methodological quality.
Moving the investigators' focus from macrohemodynamic to microhemodynamic monitoring is now
essential and due to recent technological advances, severe impairments in microcirculatory
perfusion are now being recognized in various pathological states. What is now clear from
various studies is the fact that even with restoring ‘normal’ macrocirculatory parameters,
severe microcirculatory alterations can be seen.
This study is an integral part of a program aimed to explore different questions regarding
fluid resuscitation in burn patients. The aim is to characterize changes in fluid shift,
fluid accumulation, and vascular volumes after burn injury and also to study the effects of
an artificial colloid on different macrocirculatory and microcirculatory parameters. The
primary end points are:
1. fluid accumulation during the initial phase; and
2. short term effects of colloids on macrocirculatory and microcirculatory parameters.
This study will collect data on macro- and microcirculation derived from current monitoring
systems. Data (see below) will be collected at defined time points and before and after the
first two fluid challenges. If the fluid challenge occurs in a one hour time frame of a
defined time point, only one assessment will be done.
1. At defined time points: a set of data (see below) will be collected by the research
team at baseline, 6, 12, 18, 24, 36, 48 and 72 hours after burn injury. Baseline values
will be the ones obtained immediately after consent.
2. Fluid challenges: Burn patients often require additional fluid bolus to maintain
hemodynamic stability because of the following reasons: hypotension; decreased urine
output (less than 0.5 ml/kg/hour); uncorrected metabolic acidosis; rhabdomyolysis;
increasing hematocrit; or any other clinical reason according to the attending
physician.
In this study, the two first fluid challenges will be allocated according to a random list.
One bolus will be Pentaspan (500 ml) and the other will be a crystalloid solution (Ringer's
lactate 1000 ml). These two alternatives represent a true equipoise as they are equally
acceptable because choosing one of them depends on the preference of the attending
physician. Fluid challenges will be allocated using a randomised short block cross-over
sequence.
The following parameters will be measured at a fixed time and before and after the fluid
challenges using different techniques.
Parameters:
Intrathoracic blood volume, extravascular lung water, total blood volume; extracellular
edema; intraventricular preload, ventricular volumes, diastolic function; cardiac output;
mixed venous saturation; oncotic pressure; microcirculatory assessment: number and diameter
of capillaries, proportion of perfusion, and flow velocities.
This is an observational, one-group study aimed at describing macrocirculation and
microcirculation parameters in a burn patient population. The investigators arbitrarily plan
to enroll 40 patients.
n/a
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Completed |
NCT05276869 -
Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
|
||
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06076031 -
Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing
|
N/A | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
Recruiting |
NCT04090424 -
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT03159182 -
Study of Silicone Material Inserts To Treat Burn Scars
|
N/A | |
Recruiting |
NCT02904941 -
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
|
N/A | |
Completed |
NCT02681757 -
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01437852 -
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
|
Phase 1 | |
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Completed |
NCT01061502 -
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
|
Phase 1/Phase 2 | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Terminated |
NCT00634166 -
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
|
Phase 4 | |
Terminated |
NCT00824681 -
Effect of Music Therapy on Families of Burn Patients
|
Phase 1 | |
Terminated |
NCT00464386 -
Continuous Glucose Monitoring (POC) in the ICU
|
N/A | |
Withdrawn |
NCT00216983 -
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
|
N/A |